⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 42 seconds ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 42 seconds ago
🛡️ EUSW
🇬🇧
💊 Medicine AT August 24, 2026

VAQTA K pro infantibus 25 E/0,5 ml Injektionssuspension in einer Fertigspritze 25 E/0,5 ml (Injektionssuspension in einer Fertigspritze)

📷 Wikipedia: Hepatitis A virus internal ribosome entry site (IRES) · Source
VAQTA K pro infantibus 25 E/0,5 ml Injektionssuspension in einer Fertigspritze 25 E/0,5 ml (Injektionssuspension in einer Fertigspritze)
📷 Wikipedia: Hepatitis A virus internal ribosome entry site (IRES) · Source
VAQTA for infants 25 E/0.5 ml injection suspension in a pre-filled syringe is subject to a parallel export ban.
⚠️
Shortage ongoing
HEPATITIS-A-VIRUS is currently in short supply in AT.
📈 Timeline
18 days active so far
August 25, 2026 September 11, 2026

What is this? This is a vaccine that helps protect babies and young children from hepatitis A. It comes in a ready-to-use syringe.

What's happening? The vaccine is not available right now. It should be back in stock on a certain date.

Does this affect me? If you planned to get this vaccine for your child in Austria, you may need to wait.

What should I do? Ask your pharmacist or doctor for advice about when to get the vaccine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: J07BC02 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Merck Sharp & Dohme Ges.m.b.H., THE ICON VIENNA Turm A, 20. Stock, Wiedner Gürtel 9-13, 1100 Wien, Österreich · Affected packs: 1 Stück Schachtel, Fertigspritze [Nicht verfügbar, since 2026-08-24, resupply 2026-09-25]

First published
August 24, 2026
Last refreshed by us
18 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
VAQTA K pro infantibus 25 E/0,5 ml Injektionssuspension in einer Fertigspritze 25 E/0,5 ml (Injektionssuspension in einer Fertigspritze). VAQTA for infants 25 E/0.5 ml injection suspension in a pre-filled syringe is subject to a parallel export ban.
When was this alert issued?
This alert was issued on August 24, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.